2 insiders reported 4 Form 4 transactions for Salarius Pharmaceuticals, Inc. (SLRX) over the past 18 months (most recent 2026-01-02). Recent activity: HANISH ARNOLD C (Director) Sell 15 shares, HANISH ARNOLD C (Director) Sell 12 shares, HANISH ARNOLD C (Director) Buy 5,000 shares, Rosenblum Mark J (Exec VP Finance, CFO) Buy 20,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-02 | HANISH ARNOLD C | Director | Sell | 15 | $10 |
| 2026-01-02 | HANISH ARNOLD C | Director | Sell | 12 | $8 |
| 2025-11-24 | HANISH ARNOLD C | Director | Buy | 5,000 | $3,750 |
| 2025-11-20 | Rosenblum Mark J | Exec VP Finance, CFO | Buy | 20,000 | $16,000 |
Source: SEC Form 4 filings · as of 2026-01-02
